Header Logo

Connection

RICHA SHUKLA to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications RICHA SHUKLA has written about Antibodies, Monoclonal, Humanized.
RICHA SHUKLA
Connection Strength
0.656
Antibodies, Monoclonal, Humanized
  1. Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Ther. 2024 Sep-Oct 01; 31(5):e596-e600.
    View in: PubMed
    Score: 0.656
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.